Join the Reckitt Benckiser Group PLC Class Action
Investors holding American Depositary Shares (ADSs) of Reckitt Benckiser Group PLC (OTC: RBGLY) have an important opportunity. If you invested in Reckitt ADSs from January 13, 2021, to July 28, 2024, you may qualify to join a class action lawsuit. The deadline for potential lead plaintiff submissions is fast approaching, set for August 4, 2025.
Understanding the Lawsuit
This lawsuit arises from allegations that Reckitt Benckiser misled investors regarding their infant formula product, Enfamil. The suit claims that during the class period, Reckitt failed to disclose significant risks associated with the health of preterm infants consuming their product. These oversights have allegedly led to substantial financial losses for investors.
The Importance of Participating
Participating in this class action may entitle you to compensation without any upfront costs. Legal fees can be covered through a contingency fee agreement, meaning you don’t have to pay out of pocket unless you win. This is a great opportunity for those who have suffered losses exceeding $100,000.
Legal Guidance and Support
The Rosen Law Firm, known for its expertise in securities class actions, encourages potential claimants to take action. Previous settlements achieved by the firm show a strong track record in advocating for investor rights. They have recovered substantial amounts for their clients, including over $438 million in one year alone. With numerous awards and recognitions, selecting a reputable firm is critical to navigating these challenges.
Case Details and Implications
As noted in the lawsuit, Reckitt Benckiser's failure to inform investors about the risks linked to its Enfamil formula resulted in misleading statements about the company's health and market performance. When the real information came to light, investors faced significant financial setbacks. Understanding the implications of these allegations is crucial for class members and potential claimants.
How to Proceed
Investors interested in joining the lawsuit should act swiftly. To be part of this legal action, you can visit the official website or contact legal representatives. This is not only a chance for potential recovery but also an opportunity to hold corporations accountable for their disclosures.
Ongoing Updates and Communication
For those interested in updates or more information on the class action process, staying connected is vital. Engaging with the legal firm’s social media can provide real-time information on developments and relevant changes.
Frequently Asked Questions
What is the deadline to join the Reckitt Benckiser class action?
The deadline to participate as a lead plaintiff is August 4, 2025.
What compensation can I expect if I join the class action?
Compensation will depend on the outcome of the lawsuit, but all legal fees are typically covered by the firm unless you win.
Why should I choose the Rosen Law Firm?
The Rosen Law Firm has a proven record of success in securities class actions, having secured substantial settlements for investors.
What are the risks associated with the Reckitt Benckiser products?
The lawsuit alleges that Reckitt failed to disclose risks related to its Enfamil formula, which could lead to severe health issues in infants.
Can I still participate if I didn’t purchase Reckitt stocks directly?
If you purchased Reckitt ADSs within the specified timeframe, you are eligible to participate in the action.
